Liver plays a central role in asymmetric dimethylargininemediated organ injury

World Journal of Gastroenterology

Volumn 21, Issue 17, 2015, Pages 5131-5137

  Ferrigno, Andrea ^a   Di Pasqua, Laura G ^a   Berardo, Clarissa ^a   Richelmi, Plinio ^a   Vairetti, Mariapia ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Asymmetric dimethylarginine; Liver; Multiple organ failure; Nitric oxide; Nitric oxide synthase

Indexed keywords

N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; ARGININE; BIOLOGICAL MARKER; N,N-DIMETHYLARGININE;

ACUTE LIVER FAILURE; ALCOHOL LIVER DISEASE; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ARTICLE; CARDIOVASCULAR RISK; CRITICALLY ILL PATIENT; ENZYME ACTIVITY; EXCRETION; GENETIC POLYMORPHISM; HUMAN; INTENSIVE CARE UNIT; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION; MULTIPLE ORGAN FAILURE; NONHUMAN; ORGAN INJURY; OXIDATIVE STRESS; PROTEIN METABOLISM; PROTEIN METHYLATION; SYNTHESIS; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; CRITICAL ILLNESS; LIVER DISEASES; METABOLISM; PATHOLOGY; PROGNOSIS; RISK FACTOR; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; ARGININE; BIOMARKERS; CRITICAL ILLNESS; HUMANS; LIVER; LIVER DISEASES; MULTIPLE ORGAN FAILURE; PROGNOSIS; RISK FACTORS; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84929008280     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i17.5131     Document Type: Article

References (51)

1. Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339: 572-575 [PMID: 1347093]
2. Förstermann U, Schmidt HH, Pollock JS, Sheng H, Mitchell JA, Warner TD, Nakane M, Murad F. Isoforms of nitric oxide synthase. Characterization and purification from different cell types. Biochem Pharmacol 1991; 42: 1849-1857 [PMID: 1720618]
3. Hattori Y, Kasai K, Gross SS. Cationic amino acid transporter gene expression in cultured vascular smooth muscle cells and in rats. Am J Physiol 1999; 276: H2020-H2028 [PMID: 10362683]
4. Closs EI, Gräf P, Habermeier A, Cunningham JM, Förstermann U. Human cationic amino acid transporters hCAT-1, hCAT-2A, and hCAT-2B: three related carriers with distinct transport properties. Biochemistry 1997; 36: 6462-6468 [PMID: 9174363 DOI: 10.1021/bi962829p]
5. Zakrzewicz D, Eickelberg O. From arginine methylation to ADMA: a novel mechanism with therapeutic potential in chronic lung diseases. BMC Pulm Med 2009; 9 [PMID: 19178698 DOI: 10.1186/1471-2466-9-5]
6. Teerlink T. ADMA metabolism and clearance. Vasc Med 2005; 10 Suppl 1: S73-S81 [PMID: 16444872]
7. MacAllister RJ, Parry H, Kimoto M, Ogawa T, Russell RJ, Hodson H, Whitley GS, Vallance P. Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. Br J Pharmacol 1996; 119: 1533-1540 [PMID: 8982498]
8. Kimoto M, Tsuji H, Ogawa T, Sasaoka K. Detection of NG,NGdimethylarginine dimethylaminohydrolase in the nitric oxidegenerating systems of rats using monoclonal antibody. Arch Biochem Biophys 1993; 300: 657-662 [PMID: 8434946 DOI: 10.1006/abbi.1993.1091]
9. Kimoto M, Whitley GS, Tsuji H, Ogawa T. Detection of NG,NGdimethylarginine dimethylaminohydrolase in human tissues using a monoclonal antibody. J Biochem 1995; 117: 237-238 [PMID: 7608105]
10. Murray-Rust J, Leiper J, McAlister M, Phelan J, Tilley S, Santa Maria J, Vallance P, McDonald N. Structural insights into the hydrolysis of cellular nitric oxide synthase inhibitors by dimethylarginine dimethylaminohydrolase. Nat Struct Biol 2001; 8: 679-683 [PMID: 11473257 DOI: 10.1038/90387]
11. Palm F, Onozato ML, Luo Z, Wilcox CS. Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems. Am J Physiol Heart Circ Physiol 2007; 293: H3227-H3245 [PMID: 17933965 DOI: 10.1152/ajpheart.00998.2007]
12. Nijveldt RJ, Teerlink T, Siroen MP, van Lambalgen AA, Rauwerda JA, van Leeuwen PA. The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA). Clin Nutr 2003; 22: 17-22 [PMID: 12553945]
13. Zoccali C. Asymmetric dimethylarginine in end-stage renal disease patients: a biomarker modifiable by calcium blockade and angiotensin II antagonism? Kidney Int 2006; 70: 2053-2055 [PMID: 17136131 DOI: 10.1038/sj.ki.5001898]
14. Ferrigno A, Rizzo V, Bianchi A, Di Pasqua LG, Berardo C, Richelmi P, Vairetti M. Changes in ADMA/DDAH pathway after hepatic ischemia/reperfusion injury in rats: the role of bile. Biomed Res Int 2014; 2014: 627434 [PMID: 25243167 DOI: 10.1155/2014/627434]
15. Mookerjee RP, Dalton RN, Davies NA, Hodges SJ, Turner C, Williams R, Jalan R. Inflammation is an important determinant of levels of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) in acute liver failure. Liver Transpl 2007; 13: 400-405 [PMID: 17318866 DOI: 10.1002/lt.21053]
16. Kielstein JT, Zoccali C. Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age? Am J Kidney Dis 2005; 46: 186-202 [PMID: 16112037 DOI: 10.1053/j.ajkd.2005.05.009]
17. He H, Wang S, Li X, Wang H, Zhang W, Yuan L, Liu X. A novel metabolic balance model for describing the metabolic disruption of and interactions between cardiovascular-related markers during acute myocardial infarction. Metabolism 2013; 62: 1357-1366 [PMID: 23702382 DOI: 10.1016/j.metabol.2013.04.011]
18. Nijveldt RJ, Teerlink T, van Leeuwen PA. The asymmetrical dimethylarginine (ADMA)-multiple organ failure hypothesis. Clin Nutr 2003; 22: 99-104 [PMID: 12553957 DOI: 10.1054/clnu.2002.0614]
19. Davis JS, Darcy CJ, Yeo TW, Jones C, McNeil YR, Stephens DP, Celermajer DS, Anstey NM. Asymmetric dimethylarginine, endothelial nitric oxide bioavailability and mortality in sepsis. PLoS One 2011; 6: e17260 [PMID: 21364995 DOI: 10.1371/journal.pone.0017260]
20. Lluch P, Torondel B, Medina P, Segarra G, Del Olmo JA, Serra MA, Rodrigo JM. Plasma concentrations of nitric oxide and asymmetric dimethylarginine in human alcoholic cirrhosis. J Hepatol 2004; 41: 55-59 [PMID: 15246208 DOI: 10.1016/j.jhep.2004.03.016]
21. Mookerjee RP, Malaki M, Davies NA, Hodges SJ, Dalton RN, Turner C, Sen S, Williams R, Leiper J, Vallance P, Jalan R. Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis. Hepatology 2007; 45: 62-71 [PMID: 17187433 DOI: 10.1002/hep.21491]
22. Nijveldt RJ, Teerlink T, Van Der Hoven B, Siroen MP, Kuik DJ, Rauwerda JA, van Leeuwen PA. Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality. Clin Nutr 2003; 22: 23-30 [PMID: 12553946]
23. Siroen MP, Warlé MC, Teerlink T, Nijveldt RJ, Kuipers EJ, Metselaar HJ, Tilanus HW, Kuik DJ, van der Sijp JR, Meijer S, van der Hoven B, van Leeuwen PA. The transplanted liver graft is capable of clearing asymmetric dimethylarginine. Liver Transpl 2004; 10: 1524-1530 [PMID: 15558588 DOI: 10.1002/lt.20286]
24. Martín-Sanz P, Olmedilla L, Dulin E, Casado M, Callejas NA, Pérez-Peña J, Garutti I, Sanz J, Calleja J, Barrigón S, Boscá L. Presence of methylated arginine derivatives in orthotopic human liver transplantation: relevance for liver function. Liver Transpl 2003; 9: 40-48 [PMID: 12514772 DOI: 10.1053/jlts.2003.50008]
25. Brenner T, Fleming TH, Rosenhagen C, Krauser U, Mieth M, Bruckner T, Martin E, Nawroth PP, Weigand MA, Bierhaus A, Hofer S. L-arginine and asymmetric dimethylarginine are early predictors for survival in septic patients with acute liver failure. Mediators Inflamm 2012; 2012: 210454 [PMID: 22619480 DOI: 10.1155/2012/210454]
26. Trocha M, Merwid-Ląd A, Chlebda-Sieragowska E, Szuba A, Pies̈niewska M, Fereniec-Gołębiewska L, Kwiatkowska J, Szeląg A, Sozański T. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion. Exp Gerontol 2014; 50: 45-51 [PMID: 24269305 DOI: 10.1016/j.exger.2013.11.004]
27. Lanteri R, Acquaviva R, Di Giacomo C, Sorrenti V, Li Destri G, Santangelo M, Vanella L, Di Cataldo A. Rutin in rat liver ischemia/reperfusion injury: effect on DDAH/NOS pathway. Microsurgery 2007; 27: 245-251 [PMID: 17477412 DOI: 10.1002/micr.20345]
28. Davids M, Richir MC, Visser M, Ellger B, van den Berghe G, van Leeuwen PA, Teerlink T. Role of dimethylarginine dimethylaminohydrolase activity in regulation of tissue and plasma concentrations of asymmetric dimethylarginine in an animal model of prolonged critical illness. Metabolism 2012; 61: 482-490 [PMID: 22000584 DOI: 10.1016/j.metabol.2011.08.007]
29. Chang KA, Lin IC, Sheen JM, Chen YC, Chen CC, Tain YL, Hsieh CS, Huang LT. Sex differences of oxidative stress to cholestatic liver and kidney injury in young rats. Pediatr Neonatol 2013; 54: 95-101 [PMID: 23590953 DOI: 10.1016/j.pedneo.2012.11.008]
30. Yang YY, Lee TY, Huang YT, Chan CC, Yeh YC, Lee FY, Lee SD, Lin HC. Asymmetric dimethylarginine (ADMA) determines the improvement of hepatic endothelial dysfunction by vitamin E in cirrhotic rats. Liver Int 2012; 32: 48-57 [PMID: 22098317 DOI: 10.1111/j.1478-3231.2011.02651.x]
31. Ferrigno A, Palladini G, Bianchi A, Rizzo V, Di Pasqua LG, Perlini S, Richelmi P, Vairetti M. Lobe-specific heterogeneity in asymmetric dimethylarginine and matrix metalloproteinase levels in a rat model of obstructive cholestasis. Biomed Res Int 2014; 2014: 327537 [PMID: 25013773 DOI: 10.1155/2014/327537]
32. Böger RH, Bode-Böger SM, Sydow K, Heistad DD, Lentz SR. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia. Arterioscler Thromb Vasc Biol 2000; 20: 1557-1564 [PMID: 10845872]
33. Böger RH, Bode-Böger SM, Szuba A, Tsao PS, Chan JR, Tangphao O, Blaschke TF, Cooke JP. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 1998; 98: 1842-1847 [PMID: 9799202]
34. Baue AE, Durham R, Faist E. Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): are we winning the battle? Shock 1998; 10: 79-89 [PMID: 9721973 DOI: 10.1097/00024382-199808000-00001]
35. López A, Lorente JA, Steingrub J, Bakker J, McLuckie A, Willatts S, Brockway M, Anzueto A, Holzapfel L, Breen D, Silverman MS, Takala J, Donaldson J, Arneson C, Grove G, Grossman S, Grover R. Multiple-center, randomized, placebocontrolled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 2004; 32: 21-30 [PMID: 14707556 DOI: 10.1097/01.CCM.0000105581.01815.C6]
36. Nathan CF, Hibbs JB. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 1991; 3: 65-70 [DOI: 10.1016/0952-7915(91)90079-G]
37. Förstermann U, Sessa WC. Nitric oxide synthases: regulation and function. Eur Heart J 2012; 33: 829-837, 837a-837d [PMID: 21890489 DOI: 10.1093/eurheartj/ehr304]
38. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-2012 [PMID: 7504210 DOI: 10.1056/NEJM199312303292706]
39. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995; 377: 239-242 [PMID: 7545787 DOI: 10.1038/377239a0]
40. Avontuur JA, Bruining HA, Ince C. Inhibition of nitric oxide synthesis causes myocardial ischemia in endotoxemic rats. Circ Res 1995; 76: 418-425 [PMID: 7532118 DOI: 10.1161/01. RES.76.3.418]
41. Visser M, Paulus WJ, Vermeulen MA, Richir MC, Davids M, Wisselink W, de Mol BA, van Leeuwen PA. The role of asymmetric dimethylarginine and arginine in the failing heart and its vasculature. Eur J Heart Fail 2010; 12: 1274-1281 [PMID: 20923854 DOI: 10.1093/eurjhf/hfq158]
42. Böger RH. Live and let die: asymmetric dimethylarginine and septic shock. Crit Care 2006; 10: 169 [PMID: 17094795 DOI: 10.1186/cc5076]
43. Leiper J, Murray-Rust J, McDonald N, Vallance P. S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase. Proc Natl Acad Sci USA 2002; 99: 13527-13532 [PMID: 12370443 DOI: 10.1073/pnas.212269799]
44. Harbrecht BG, Doyle HR, Clancy KD, Townsend RN, Billiar TR, Peitzman AB. The impact of liver dysfunction on outcome in patients with multiple injuries. Am Surg 2001; 67: 122-126 [PMID: 11243533]
45. Brinkmann SJ, de Boer MC, Buijs N, van Leeuwen PA. Asymmetric dimethylarginine and critical illness. Curr Opin Clin Nutr Metab Care 2014; 17: 90-97 [PMID: 24281375 DOI: 10.1097/MCO.0000000000000020]
46. Nijveldt RJ, Teerlink T, Siroen MP, van der Hoven B, Prins HA, Wiezer MJ, Meijer C, van der Sijp JR, Cuesta MA, Meijer S, van Leeuwen PA. Elevation of asymmetric dimethylarginine (ADMA) in patients developing hepatic failure after major hepatectomy. JPEN J Parenter Enteral Nutr 2004; 28: 382-387 [PMID: 15568284]
47. O'Dwyer MJ, Dempsey F, Crowley V, Kelleher DP, McManus R, Ryan T. Septic shock is correlated with asymmetrical dimethyl arginine levels, which may be influenced by a polymorphism in the dimethylarginine dimethylaminohydrolase II gene: a prospective observational study. Crit Care 2006; 10: R139 [PMID: 17002794 DOI: 10.1186/cc5053]
48. Sheen JM, Chen YC, Tain YL, Huang LT. Increased circulatory asymmetric dimethylarginine and multiple organ failure: bile duct ligation in rat as a model. Int J Mol Sci 2014; 15: 3989-4006 [PMID: 24603538 DOI: 10.3390/ijms15033989]
49. Zhang DL, Liu J, Liu S, Zhang Y, Liu WH. The differences of asymmetric dimethylarginine removal by different dialysis treatments. Ren Fail 2010; 32: 935-940 [PMID: 20722560 DOI: 10.3109/0886022X.2010.502281]
50. Abedini S, Meinitzer A, Holme I, März W, Weihrauch G, Fellstrøm B, Jardine A, Holdaas H. Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipients. Kidney Int 2010; 77: 44-50 [PMID: 19847152 DOI: 10.1038/ki.2009.382]
51. Rooyackers O, Kouchek-Zadeh R, Tjäder I, Norberg A, Klaude M, Wernerman J. Whole body protein turnover in critically ill patients with multiple organ failure. Clin Nutr 2015; 34: 95-100 [PMID: 24556361 DOI: 10.1016/j.clnu.2014.01.020]